| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.016 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |